Prognostic factors for hepatocellular carcinoma recurrence

Area of Science:

• Hepatobiliary Surgery
• Medical Oncology
• Translational Research

Background:

• Hepatocellular carcinoma (HCC) recurrence is a significant clinical challenge after treatment.
• Recurrence occurs in early (within 2 years, tumor biology-related) and late phases (after 2 years, de novo formation in cirrhotic environment).
• Early and late HCC recurrences may be influenced by distinct risk factors.

Purpose of the Study:

• To identify predictive factors for hepatocellular carcinoma recurrence.
• To analyze predicting factors based on different therapeutic strategies.
• To discuss the role of emerging techniques and biological features in predicting recurrence.

Main Methods:

• Review of invasive and non-invasive methods for predicting HCC recurrence.
• Evaluation of emerging techniques like transient elastography.
• Consideration of biological features and genetic signatures of HCC.

Main Results:

• Early recurrence is linked to tumor invasiveness and intrahepatic metastasis.
• Late recurrence is associated with the cirrhotic environment and de novo tumor formation.
• Emerging non-invasive methods and genetic profiles show promise in predicting recurrence.

Conclusions:

• Recognizing distinct risk factors for early and late HCC recurrence is clinically important.
• Invasive and non-invasive methods, including genetic signatures, aid in predicting recurrence.
• Optimizing treatment strategies and surveillance follow-up for HCC patients requires understanding these predictive factors.